Bristol-Myers Squibb Co (NYSE:BMY)

54.77
Delayed Data
As of Oct 23
 +0.35 / +0.64%
Today’s Change
42.48
Today|||52-Week Range
57.37
+5.37%
Year-to-Date
3 Cancer Treatment Stocks to Buy Right Now
Oct 23 / MotleyFool.com - Paid Partner Content
Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding?
Oct 11 / MotleyFool.com - Paid Partner Content
Is Mirati Therapeutics a Good Stock to Buy Now?
Oct 20 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close54.42
Today’s open54.41
Day’s range53.87 - 54.82
Volume13,165,181
Average volume (3 months)12,131,762
Market cap$86.7B
Data as of 6:30pm ET, 10/23/2019

Growth & Valuation

Earnings growth (last year)+393.92%
Earnings growth (this year)+7.78%
Earnings growth (next 5 years)+10.10%
Revenue growth (last year)+8.59%
P/E ratio14.5
Price/Sales3.77
Price/Book6.14

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.21+0.39%
CELGCelgene+0.29+0.28%
LLYEli Lilly and Co-2.44-2.22%
GSKGlaxoSmithKline+0.75+1.76%
Data as of 6:30pm ET, 10/23/2019

Financials

Next reporting dateOctober 31, 2019
EPS forecast (this quarter)$1.07
Annual revenue (last year)$22.6B
Annual profit (last year)$4.9B
Net profit margin21.81%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts